Yonatan Perez1, Rotem Kadir1, Michael Volodarsky1, Iris Noyman2, Hagit Flusser3, Zamir Shorer2, Libe Gradstein4, Ramon Y Birnbaum5, Ohad S Birk6. 1. The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. 2. Pediatric Neurology Unit, Division of Pediatrics, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel. 3. Zussman Child Development Center, Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel. 4. Department of Ophthalmology, Faculty of Health Sciences, Soroka Medical Center and Clalit Health Services, Ben-Gurion University of the Negev, Beer Sheva, Israel. 5. Department of Life Sciences, Faculty of Natural Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. 6. The Morris Kahn Laboratory of Human Genetics, National Institute for Biotechnology in the Negev, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel Genetics Institute, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Abstract
BACKGROUND: A syndrome of profound hypotonia, intellectual disability, intrauterine growth retardation with subsequent failure to thrive, dyskinesia and epilepsy was diagnosed in Bedouin Israeli families. Mild dysmorphism was evident: plagiocephaly, broad forehead with prominent nose, smooth philtrum and congenital esotropia. We set out to decipher the molecular basis of this syndrome. METHODS: Genome-wide linkage analysis and fine mapping were done. Whole exome sequencing data were filtered for candidate variants within locus. Validation and segregation of the mutation was assayed via Sanger sequencing. UNC80 expression pattern was analysed through reverse transcription PCR. RESULTS: Homozygosity mapping followed by fine mapping identified a 7.5 Mb disease-associated locus (logarithm of odds score 3.5) on chromosome 2. Whole exome and Sanger sequencing identified a single homozygous nonsense mutation within this locus, segregating within the families as expected for recessive heredity and not found in a homozygous state in 150 Bedouin controls: c.151C>T, p.(R51*) in UNC80. CONCLUSIONS: The syndrome described is caused by a mutation in UNC80, truncating most of the 3258 amino acids highly conserved encoded protein, that has no known motifs. UNC80 bridges between UNC79 and the cation channel NALCN, enabling NALCN's role in basal Na(+) leak conductance in neurons, essential for neuronal function. The phenotype caused by the UNC80 mutation resembles that previously described for homozygous NALCN mutations. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND: A syndrome of profound hypotonia, intellectual disability, intrauterine growth retardation with subsequent failure to thrive, dyskinesia and epilepsy was diagnosed in Bedouin Israeli families. Mild dysmorphism was evident: plagiocephaly, broad forehead with prominent nose, smooth philtrum and congenital esotropia. We set out to decipher the molecular basis of this syndrome. METHODS: Genome-wide linkage analysis and fine mapping were done. Whole exome sequencing data were filtered for candidate variants within locus. Validation and segregation of the mutation was assayed via Sanger sequencing. UNC80 expression pattern was analysed through reverse transcription PCR. RESULTS: Homozygosity mapping followed by fine mapping identified a 7.5 Mb disease-associated locus (logarithm of odds score 3.5) on chromosome 2. Whole exome and Sanger sequencing identified a single homozygous nonsense mutation within this locus, segregating within the families as expected for recessive heredity and not found in a homozygous state in 150 Bedouin controls: c.151C>T, p.(R51*) in UNC80. CONCLUSIONS: The syndrome described is caused by a mutation in UNC80, truncating most of the 3258 amino acids highly conserved encoded protein, that has no known motifs. UNC80 bridges between UNC79 and the cation channel NALCN, enabling NALCN's role in basal Na(+) leak conductance in neurons, essential for neuronal function. The phenotype caused by the UNC80 mutation resembles that previously described for homozygous NALCN mutations. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: Hanna Hong; Rory Kamerman-Kretzmer; Roberta Kato; Tena Rosser; Michele VanHirtum-Das; Sally L Davidson Ward Journal: J Clin Sleep Med Date: 2018-08-15 Impact factor: 4.062
Authors: Elise Valkanas; Katherine Schaffer; Christopher Dunham; Valerie Maduro; Christèle du Souich; Rosemarie Rupps; David R Adams; Alireza Baradaran-Heravi; Elise Flynn; May C Malicdan; William A Gahl; Camilo Toro; Cornelius F Boerkoel Journal: Am J Med Genet A Date: 2016-08-11 Impact factor: 2.802
Authors: Claudia Weidling; Nourdine Chakouri; Cameron L Noland; Marc Kschonsak; Han Chow Chua; Katharina Schott; Timothy Chang; Christine Tam; Nidhi Patel; Christopher P Arthur; Alexander Leitner; Manu Ben-Johny; Claudio Ciferri; Stephan Alexander Pless; Jian Payandeh Journal: Nature Date: 2021-12-20 Impact factor: 69.504
Authors: Jessica X Chong; Viviana Caputo; Ian G Phelps; Lorenzo Stella; Lisa Worgan; Jennifer C Dempsey; Alina Nguyen; Vincenzo Leuzzi; Richard Webster; Antonio Pizzuti; Colby T Marvin; Gisele E Ishak; Simone Ardern-Holmes; Zara Richmond; Michael J Bamshad; Xilma R Ortiz-Gonzalez; Marco Tartaglia; Maya Chopra; Dan Doherty Journal: Am J Hum Genet Date: 2016-03-31 Impact factor: 11.043